Today’s top gainers include the company Zoetis Inc. (NYSE:ZTS) which is in the industry Drugs – Generic, gaining -0.10% today. In the last week its performance is 2.15%, and 3.89% for the past quarter. Currently, Zoetis Inc., ZTS has a target price of 52.7, so today’s gain of -0.10% is a significant step towards its target price. The GAP today is therefore -0.08%.
Zoetis Inc. (NYSE:ZTS), has a market cap of 25084.8, and is based in USA. Insider ownership is at 0.01%, and institutional ownership is 91.60%.
At the current price of 50.2, it has a dividend yield of 0.76%, and its target price is 52.7. This is with a profit margin of 7.80%, and total debt/equity of 3.84. Zoetis Inc. (NYSE:ZTS) has a P/E of 66.38, as well as a forward P/E of 21.89.
With a current EPS of 0.76, and a forecasted EPS growth for next year at 23.04%,Zoetis Inc. (NYSE:ZTS) has had a EPS growth for the past five years at 25.10%. For the next five years EPS growth is projected to be 12.58%.
Performance for the year is 3.32%. Since its IPO date on 2/1/2013, the total performance to date is 5.53%.
Volume today for Zoetis Inc. (NYSE:ZTS), is 1044787, while its average volume is 3354.97. Whilst the total gain today was -0.10%, it did have a day high of -0.28%.
Volatility for this week has been at 1.49%, and 1.59% for the month. The 52-week low for Zoetis Inc., ZTS has been 34.15%, while the 52-week-high has reached -0.28%.
Looking at its return of investments, which is 5.70%, and its return on assets is 5.30%. Zoetis Inc. (NYSE:ZTS) has an operating margin of 13.40%. With a sales growth of 5.40% quarter over quarter. Bearing in mind that Zoetis Inc., ZTS is in the sector Healthcare, its long-term debt/equity is 3.83, and has a current ratio of 2.8 and 1.6 for quick ratio.
So what is the value of Zoetis Inc.? Well its PEG is 5.28, and the P/S is 5.2, along with a P/B of 21.47. Meanwhile it has a p/cash of 37.16.